AMH Gene

HGNC Family	Endogenous ligands
Name	anti-Mullerian hormone
Description	This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate N- and C-terminal cleavage products that homodimerize and associate to form a biologically active noncovalent complex. This complex binds to the anti-Mullerian hormone receptor type 2 and causes the regression of Mullerian ducts in the male embryo that would otherwise differentiate into the uterus and fallopian tubes. This protein also plays a role in Leydig cell differentiation and function and follicular development in adult females. Mutations in this gene result in persistent Mullerian duct syndrome. [provided by RefSeq, Jul 2016]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Anti‐Müllerian hormone (AMH) is a member of the transforming growth factor‐β superfamily that plays multifaceted roles in reproductive function. In women, AMH is secreted almost exclusively by the granulosa cells of growing follicles—from primary and secondary (preantral) up to small antral stages—and is absent from primordial follicles. In this context, AMH acts as an important “gatekeeper” for folliculogenesis by inhibiting premature recruitment of primordial follicles and by modulating follicular sensitivity to follicle‐stimulating hormone (FSH) during the selection of the dominant follicle."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Its serum concentration is closely correlated with the antral follicle count and, consequently, with the size of the ovarian reserve. As women age, AMH levels decline—reaching notably low or undetectable levels several years before menopause—making it a robust endocrine marker of ovarian aging."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In women with polycystic ovary syndrome (PCOS), serum AMH concentrations are substantially elevated due to an increased pool of small antral follicles, and this overexpression is thought to contribute to the characteristic follicular arrest by negatively interfacing with FSH‐dependent maturation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, AMH’s stability during the menstrual cycle and its strong association with oocyte yield in assisted reproductive protocols further support its utility as a clinical biomarker for predicting ovarian response and live‐birth outcomes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": " In addition, longitudinal studies indicate that while AMH declines over time in all women, its rate of decrease is less pronounced in PCOS patients"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", and elevated prenatal AMH in PCOS appears to influence offspring neuroendocrine programming, potentially predisposing them to a PCOS‐like phenotype."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In contrast, in the male reproductive system AMH is produced by immature Sertoli cells and is crucial during embryogenesis for inducing Müllerian duct regression; although its production decreases at puberty, residual secretion persists into adulthood."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Collectively, these findings establish AMH as not only a key regulator of early follicular development and ovarian reserve dynamics but also as a reliable marker in clinical settings for assessing ovarian function, predicting response to treatment, and understanding the pathophysiology of conditions like PCOS. The consistent profile of AMH, regardless of menstrual cycle phase"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ", further underscores its diagnostic and prognostic value in reproductive medicine.\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n (1–16)\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Christien Weenen, Joop S E Laven, Anne R M Von Bergh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Hum Reprod (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/molehr/gah015"}], "href": "https://doi.org/10.1093/molehr/gah015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14742691"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14742691"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "I A J van Rooij, F J M Broekmans, E R te Velde, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/17.12.3065"}], "href": "https://doi.org/10.1093/humrep/17.12.3065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12456604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12456604"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "MaryFran R Sowers, Aimee D Eyvazzadeh, Daniel McConnell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-0567"}], "href": "https://doi.org/10.1210/jc.2008-0567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18593767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18593767"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Marlies E Kevenaar, Mohamed F Meerasahib, Piet Kramer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2005-1588"}], "href": "https://doi.org/10.1210/en.2005-1588"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16556768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16556768"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Pascal Pigny, Emilie Merlen, Yann Robert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2003-030727"}], "href": "https://doi.org/10.1210/jc.2003-030727"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14671196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14671196"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Renato Fanchin, Luca Maria Schonäuer, Claudia Righini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/deg042"}], "href": "https://doi.org/10.1093/humrep/deg042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12571168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12571168"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "S Tsepelidis, F Devreker, I Demeestere, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/dem101"}], "href": "https://doi.org/10.1093/humrep/dem101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17485437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17485437"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Joan-Carles Arce, Antonio La Marca, Bjarke Mirner Klein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fertil Steril (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.fertnstert.2012.12.048"}], "href": "https://doi.org/10.1016/j.fertnstert.2012.12.048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23394782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23394782"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Laura Pellatt, Suman Rice, Helen D Mason "}, {"type": "b", "children": [{"type": "t", "text": "Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reproduction (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/REP-09-0415"}], "href": "https://doi.org/10.1530/REP-09-0415"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20207725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20207725"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Joop S E Laven, Annemarie G M G J Mulders, Jenny A Visser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2003-030932"}], "href": "https://doi.org/10.1210/jc.2003-030932"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14715867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14715867"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Annemarie G M G J Mulders, Joop S E Laven, Marinus J C Eijkemans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/deh373"}], "href": "https://doi.org/10.1093/humrep/deh373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15217995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15217995"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Brooke Tata, Nour El Houda Mimouni, Anne-Laure Barbotin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41591-018-0035-5"}], "href": "https://doi.org/10.1038/s41591-018-0035-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29760445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29760445"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ajay Kumar, Bhanu Kalra, Amita Patel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development of a second generation anti-Müllerian hormone (AMH) ELISA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Methods (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jim.2010.08.011"}], "href": "https://doi.org/10.1016/j.jim.2010.08.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20801125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20801125"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Najiba Lahlou, Ilene Fennoy, Jean-Claude Carel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibin B and anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2003-031624"}], "href": "https://doi.org/10.1210/jc.2003-031624"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15070957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15070957"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Asli Somunkiran, Tevfik Yavuz, Oguz Yucel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Obstet Gynecol Reprod Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejogrb.2007.01.012"}], "href": "https://doi.org/10.1016/j.ejogrb.2007.01.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17335955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17335955"}]}]}]}
Synonyms	MIF, MIS
Proteins	MIS_HUMAN
NCBI Gene ID	268
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

AMH has 6,824 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 111 datasets.

Click the + buttons to view associations for AMH from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

AMH Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of AMH gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of AMH gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of AMH gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of AMH gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of AMH gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of AMH gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of AMH gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of AMH gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	small molecule perturbations changing expression of AMH gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of AMH gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of AMH gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CCLE Cell Line Proteomics	Cell lines associated with AMH protein from the CCLE Cell Line Proteomics dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with AMH gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of AMH gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of AMH gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of AMH gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	ClinVar Gene-Phenotype Associations 2025	phenotypes associated with AMH gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of AMH gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing AMH protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing AMH protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with AMH protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with AMH protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with AMH gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with AMH gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	CTD Gene-Disease Associations	diseases associated with AMH gene/protein from the curated CTD Gene-Disease Associations dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by AMH gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DISEASES Curated Gene-Disease Association Evidence Scores	diseases involving AMH gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Curated Gene-Disease Association Evidence Scores 2025	diseases involving AMH gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores 2025	diseases associated with AMH gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with AMH gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with AMH gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with AMH gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with AMH gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at AMH gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of AMH gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of AMH gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing AMH from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
	GAD Gene-Disease Associations	diseases associated with AMH gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
	GAD High Level Gene-Disease Associations	diseases associated with AMH gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
	GDSC Cell Line Gene Expression Profiles	cell lines with high or low expression of AMH gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.